Total Voting Rights
May 11 2009 - 9:08AM
UK Regulatory
TIDMHIK
RNS Number : 0363S
Hikma Pharmaceuticals Plc
11 May 2009
Hikma Pharmaceuticals PLC - Voting Rights and Capital
LONDON, 11 May 2009: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) notifies
the market that as at 8 May 2009 its capital consists of 189,980,407 ordinary
shares with voting rights. There are no shares held in treasury.
The above figure (189,980,407) may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, Hikma Pharmaceuticals PLC
under the FSA's Disclosure and Transparency Rules.
- ENDS -
Enquiries:
+--------------------------------+------------------------------------+
| Hikma Pharmaceuticals PLC | |
+--------------------------------+------------------------------------+
| Henry Knowles | +44 20 7399 2760 |
| Company Secretary | |
| | |
+--------------------------------+------------------------------------+
| | |
+--------------------------------+------------------------------------+
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: "Branded", "Injectables" and "Generics".
Hikma's operations are based principally in the Middle East and North Africa
("MENA") region, where it is a market leader and sells across 17 countries, the
United States and Europe. In 2008, the Group achieved revenues of $580.7
million (2007 $449 million) and profit attributable to shareholders was $57.1
million (2007 $63 million). For news and other information, please visit
www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVREADSFFEPNEFE
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024